These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3082571)

  • 41. Auranofin therapy in rheumatoid arthritis.
    Bernhard GC
    J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Basic therapy of rheumatoid arthritis with auranofin].
    Goebel KM
    Dtsch Med Wochenschr; 1985 Jan; 110(2):64-5. PubMed ID: 3917898
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies of the intestinal metabolism of oral gold.
    Weisman MH; Hardison WG; Walz DT
    J Rheumatol; 1980; 7(5):633-8. PubMed ID: 6777493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Auranofin].
    Ferrari M; Piro MT
    Recenti Prog Med; 1983 Aug; 74(8):968-70. PubMed ID: 6417742
    [No Abstract]   [Full Text] [Related]  

  • 45. Small intestine ultrastructural changes and auranofin treatment in rheumatoid arthritis.
    Higgens C; Moss J; Woodrow D; Black C
    Br J Rheumatol; 1986 May; 25(2):227. PubMed ID: 3085761
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P; Landon M
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract]   [Full Text] [Related]  

  • 48. Modulation of neutrophil functions by auranofin. Studies on effects in vitro and in rheumatoid arthritis patients.
    Hafström I; Udén AM; Palmblad J
    Scand J Rheumatol; 1983; 12(2):97-105. PubMed ID: 6407101
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate.
    Lewis D; Capell HA
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():83-96. PubMed ID: 6432418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 52. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Auranofin (Ridaura).
    Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827
    [No Abstract]   [Full Text] [Related]  

  • 55. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 56. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.
    Larsen A; Horton J; Howland C
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():97-104. PubMed ID: 6432419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auranofin: experience to date.
    Blodgett RC
    Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.